美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Astellas Pharma, Inc.

9.28

+0.15001.64%

成交量：41.45万

成交额：385.46万

市值：172.77亿

市盈率：124.81

高：9.35

开：9.11

低：9.11

收：9.13

数据加载中...

总览公司新闻公告

美国OTC市场安斯泰莱制药盘中异动快速跳水5.99%

美国OTC市场安斯泰莱制药盘中异动股价大跌5.79%

中国国家药品监督管理局批准备思复（维恩妥尤单抗）联合可瑞达（帕博利珠单抗）用于治疗晚期膀胱癌

中国国家药品监督管理局批准威络益（佐妥昔单抗）一线治疗晚期胃或胃食管交界处腺癌

美国OTC市场安斯泰莱制药盘中异动股价大涨5.08%

美国OTC市场安斯泰莱制药盘中异动股价大涨5.25%

美国OTC市场安斯泰莱制药盘中异动早盘股价大涨5.06%报10.58美元

美国OTC市场安斯泰莱制药盘中异动早盘大幅跳水5.05%报10.37美元

美国OTC市场安斯泰莱制药盘中异动股价大跌7.12%报11.42美元

安斯泰来(ALPMY.US)CLDN18.2单抗获批一线治疗晚期癌症

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALPMY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":9.28,"timestamp":1744747200000,"preClose":9.13,"halted":0,"volume":414510,"delay":15,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"盘前交易","change":0.15,"latestTime":"04-15 16:00:00 EDT 延时","open":9.11,"high":9.35,"low":9.11,"amount":3854583.5128999976,"amplitude":0.026287,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744810200000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":9.28,"volumeRatio":0.6104676851738422},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMY\",,,,,undefined,":{"symbol":"ALPMY","floatShares":1731101601,"roa":"3.67%","roe":"-3.83%","lyrEps":0.062841,"volumeRatio":0.6104676851738422,"shares":1861787075,"dividePrice":0.504648,"high":9.35,"amplitude":0.026287,"preClose":9.13,"low":9.11,"week52Low":8.37,"pbRate":"1.65","psRate":"1.32","week52High":13.14,"institutionHeld":0,"latestPrice":9.28,"eps":0.074352,"divideRate":0.05438,"volume":414510,"delay":15,"ttmEps":0.074352,"open":9.11,"prevYearClose":9.66,"prevWeekClose":8.88,"prevMonthClose":9.66,"prevQuarterClose":9.66,"fiveDayClose":8.99,"twentyDayClose":9.963,"sixtyDayClose":9.54,"earningDate":1745424000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526851603","title":"美国OTC市场安斯泰莱制药盘中异动 快速跳水5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526851603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526851603?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 00:38","pubTimestamp":1744303139,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日00时38分，美国OTC市场安斯泰莱制药股票出现异动，股价快速下挫5.99%。截至发稿，该股报8.47美元/股，成交量28.3042万股，换手率0.02%，振幅8.32%。机构评级方面，在所有12家参与评级的机构中，33%的券商给予买入建议，58%的券商给予持有建议，9%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为4.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411003859a4552562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411003859a4552562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2508412971","title":"美国OTC市场安斯泰莱制药盘中异动 股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508412971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508412971?lang=zh_cn&edition=fundamental","pubTime":"2025-02-03 22:46","pubTimestamp":1738593977,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时46分，美国OTC市场安斯泰莱制药股票出现波动，股价快速下挫5.79%。截至发稿，该股报9.12美元/股，成交量7406股，换手率0.00%，振幅5.99%。机构评级方面，在所有14家参与评级的机构中，43%的券商给予买入建议，50%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体涨幅为0.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224617abc10ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224617abc10ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2501277310","title":"中国国家药品监督管理局批准备思复（维恩妥尤单抗）联合可瑞达（帕博利珠单抗）用于治疗晚期膀胱癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2501277310","media":"美通社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501277310?lang=zh_cn&edition=fundamental","pubTime":"2025-01-08 16:05","pubTimestamp":1736323500,"startTime":"0","endTime":"0","summary":"EV-302试验中国主要研究者、北京大学肿瘤医院泌尿肿瘤暨黑色素瘤肉瘤内科主任、中国临床肿瘤学会副理事长兼秘书长郭军教授 \"近日NMPA批准的维恩妥尤单抗联合帕博利珠单抗的治疗组合，是国内获批的首个针对晚期膀胱癌患者的非铂化疗的治疗方案，可用于一线治疗。这次批准维恩妥尤单抗联合帕博利珠单抗的治疗方案，标志着我们再一次为中国患者带来了创新治疗选择。患者随机接受维恩妥尤单抗与帕博利珠单抗联合用药治疗或含铂化疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4591653_ZH91653_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1037948541.HKD","LU0320765489.SGD","LU0006306889.USD","SG9999014567.USD","IE00B4R5TH58.HKD","LU1989771016.USD","BK4559","LU0211331839.USD","LU0965509010.AUD","LU2106854487.HKD","LU2023250843.SGD","LU2089984988.USD","LU1699723380.USD","LU0289739699.SGD","LU1061106388.HKD","IE0009355771.USD","LU1057294990.SGD","ALPMY","IE00BN8TJ469.HKD","LU0234572021.USD","LU0070302665.USD","LU1941712264.USD","SG9999014542.SGD","LU0208291251.USD","LU0985320562.USD","LU0058720904.USD","LU0106261372.USD","IE00BLSP4452.SGD","BK4007","SG9999014575.USD","IE00B2B36J28.USD","LU1291159041.SGD","LU1917777945.USD","LU1941712348.USD","LU0122379950.USD","SG9999002224.SGD","LU1974910355.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","MRK","IE0002141913.USD","BK4550","LU1116320737.USD","BK4534","LU1066051811.HKD","SGXZ57979304.SGD","IE00BSNM7G36.USD","LU0965508806.USD","LU1116320901.HKD","LU2361045086.USD"],"gpt_icon":0},{"id":"2501532952","title":"中国国家药品监督管理局批准威络益（佐妥昔单抗）一线治疗晚期胃或胃食管交界处腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2501532952","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501532952?lang=zh_cn&edition=fundamental","pubTime":"2025-01-06 20:25","pubTimestamp":1736166300,"startTime":"0","endTime":"0","summary":"胃癌是中国与癌症相关死亡的第三大因素，2022年导致超过26万例死亡。近日国家药品监督管理局批准了佐妥昔单抗在中国上市，我们非常激动，它将为我国晚期胃癌患者增添一项宝贵且有效的一线治疗选择。SPOTLIGHT研究探索了佐妥昔单抗联合化疗方案在CLDN18.2阳性、HER2阴性晚期胃和胃食管交界处癌患者一线治疗中的疗效与安全性，在PFS与OS等关键指标上，呈现出统计学上的显著差异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4589327_ZH89327_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2237443465.HKD","LU1066051811.HKD","LU1066053197.SGD","SG9999015978.USD","BK4525","SG9999015945.SGD","CDC","LU1823568750.SGD","SG9999002232.USD","BK4534","IE00BSNM7G36.USD","IE00B42XCP33.USD","LU2237443895.HKD","LU0942090050.USD","BK4515","SG9999015986.USD","IE00BGHQF631.EUR","BK4211","LU2506951958.HKD","BK4007","BK4533","LU1059921491.USD","LU1880398471.USD","LU1066051225.USD","BK4588","BK4097","BK4527","LU0823417653.USD","OS","LU0234570918.USD","IE00BVYPNV92.GBP","LU1244550221.USD","ALPMY","LU1235294995.USD","CSCO","LU1571399168.USD","LU1894683348.USD","PFS","LU2237443978.SGD","IE00BFXG1179.USD","LU2506952170.USD","IE00BVYPNW00.USD","LU2506952097.USD","LU0234572021.USD","SG9999001424.SGD","SG9999015952.SGD","LU2286300806.USD","SG9999001440.SGD","LU0950375773.USD","LU1880398554.USD"],"gpt_icon":0},{"id":"2493087988","title":"美国OTC市场安斯泰莱制药盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493087988?lang=zh_cn&edition=fundamental","pubTime":"2024-12-24 22:46","pubTimestamp":1735051571,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时46分，美国OTC市场安斯泰莱制药股票出现异动，股价大幅上涨5.08%。截至发稿，该股报10.13美元/股，成交量9.709万股，换手率0.01%，振幅7.78%。机构评级方面，在所有14家参与评级的机构中，43%的券商给予买入建议，50%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为0.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224611ab90bd69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224224611ab90bd69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2487568246","title":"美国OTC市场安斯泰莱制药盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487568246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487568246?lang=zh_cn&edition=fundamental","pubTime":"2024-11-29 22:46","pubTimestamp":1732891562,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时46分，美国OTC市场安斯泰莱制药股票出现异动，股价大幅上涨5.25%。截至发稿，该股报10.83美元/股，成交量182股，换手率0.00%，振幅0.00%。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体涨幅为0.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224602a25f7d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224602a25f7d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALPMY","BFRI","BK4007"],"gpt_icon":0},{"id":"2485418890","title":"美国OTC市场安斯泰莱制药盘中异动 早盘股价大涨5.06%报10.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485418890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485418890?lang=zh_cn&edition=fundamental","pubTime":"2024-11-21 22:46","pubTimestamp":1732200379,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时46分，美国OTC市场安斯泰莱制药股票出现波动，股价快速拉升5.06%。截至发稿，该股报10.58美元/股，成交量1841股，换手率0.00%，振幅6.75%。机构评级方面，在所有14家参与评级的机构中，50%的券商给予买入建议，43%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为1.21%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122461995be4eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122461995be4eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2483882632","title":"美国OTC市场安斯泰莱制药盘中异动 早盘大幅跳水5.05%报10.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483882632?lang=zh_cn&edition=fundamental","pubTime":"2024-11-13 22:46","pubTimestamp":1731509187,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时46分，美国OTC市场安斯泰莱制药股票出现波动，股价快速跳水5.05%。截至发稿，该股报10.37美元/股，成交量11.4641万股，换手率0.01%，振幅0.00%。机构评级方面，在所有14家参与评级的机构中，50%的券商给予买入建议，43%的券商给予持有建议，7%的券商给予卖出建议。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体涨幅为0.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322462795be2402&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322462795be2402&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2479036310","title":"美国OTC市场安斯泰莱制药盘中异动 股价大跌7.12%报11.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479036310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479036310?lang=zh_cn&edition=fundamental","pubTime":"2024-10-31 22:17","pubTimestamp":1730384221,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时17分，美国OTC市场安斯泰莱制药股票出现异动，股价大幅跳水7.12%。截至发稿，该股报11.42美元/股，成交量277股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入30.36亿美元，净利润2.41亿美元，每股收益0.13美元，毛利22.27亿美元，市盈率49.74倍。美国OTC市场安斯泰莱制药股票所在的制药行业中，整体跌幅为1.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122170195bd9d2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122170195bd9d2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALPMY"],"gpt_icon":0},{"id":"2476272862","title":"安斯泰来(ALPMY.US)CLDN18.2单抗获批一线治疗晚期癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=2476272862","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476272862?lang=zh_cn&edition=fundamental","pubTime":"2024-10-20 08:04","pubTimestamp":1729382645,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月20日，安斯泰来宣布美国FDA已批准其靶向Claudin18.2抗体Vyloy与含氟嘧啶和铂类的化疗方案联合，用于局部晚期不可切除或转移性、HER2阴性的胃癌或胃食管结合部腺癌成人患者的一线治疗，这些患者的肿瘤需通过FDA批准的检测确定为CLDN18.2阳性。根据新闻稿，Vyloy是美国FDA批准的首个CLDN18.2靶向疗法。CLDN18.2在包含胃癌在内的消化道癌症中高度表达。因此，CLDN18.2为治疗胃癌、胰腺癌等实体肿瘤的有效靶标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ALPMY","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-04","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-01","symbol":"ALPMY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722499200000,"name":null,"time":"","dateTimestamp":1722484800000,"actualEps":null},{"market":"US","date":"2024-04-25","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1683000000000}}}